Hospital for Sick Children- Toronto, Ontario, Canada
Dr Oussama Abla is a Professor of Pediatrics at the University of Toronto and a pediatric oncologist at the Hospital for Sick Children in Toronto, Canada. He is the founder and Co-Director of the Pediatric Histiocytosis Program, Director of the Histiocytosis Fellowship Program, Chair of the International Histiocytosis Clinical Rounds, and a member of the Leukemia/Lymphoma section at the Hospital for Sick Children. His clinical and research interests focus on better understanding of the biology and treatment of of Rare Histiocytic Disorders (RHD), pediatric Langerhans cell Histiocytosis, acute promyelocytic leukemia (APL) and rare childhood non-Hodgkin’s Lymphomas. He is the Co-Editor of the “Histiocytic Disorders”, “Non-Hodgkin’s Lymphoma in Childhood and Adolescence” and “Acute Promyelocytic Leukemia: A Clinical Guide” textbooks, the Principal Investigator of the International Rare Histiocytic Disorders Registry (IRHDR) and the Canadian National coordinator of the LCH-IV Trial. He is one of the founding members of the North American Histiocytosis Consortium (NACHO), Chair of the NACHO-Rare Histiocytosis Working Group, as well as a member of the NACHO-CNS-LCH and LCH working groups. He was the Chair of the Histiocyte Society-Rare Histiocytic Disorders Steering Committee for 10 years and currently remains as a member of this committee as well as a member of the Malignant Histiocytosis Task Force, and served for two terms as a member of the Histiocyte Society-Education Committee. He is also a member of the COG-ANHL2121 Trial for Relapsed LCH-Study Committee. In addition, he is the Chair of the Histiocyte Society-LCH Response Criteria Harmonization Working Group. His other interests include promoting educational materials on LCH, RHDs and APL. Dr Abla has given several interantional presentations and co-authored more than 134 publications and book chapters focused on pediatric histiocytoses and leukemia/lymphoma.
